Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Wednesday, 19 July 2017

PCAS: sustained growth in net sales


Published: 17:53 CEST 19-07-2017 /GlobeNewswire /Source: PCAS / : PCA /ISIN: FR0000053514






Longjumeau, July 19, 2017

PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales for the first half of 2017.


The PCAS Group had generated consolidated net sales of €110.2 million in the first half of 2017, representing growth of +9.4% compared to the same period during the previous financial year (+9.1% at a constant exchange rate).






Pharmaceutical Synthesis

The Pharmaceutical Synthesis business generated €75.8 million, up +10.5% on 2016 (+10.5% at a constant exchange rate), which was especially driven by the Exclusive activity.


Fine Specialty Chemicals

Net sales of Fine Specialty Chemicals totaled €34.4 million, up 7.1% on 2016 (+6.2% at a constant exchange rate), with growth in both Performance Additives and Advanced Specialty Chemicals for micro-electronic chemicals.


Outlook for the current year

The company has confirmed its growth targets for net sales in 2017 and for all its lines of business.





First half 2017 earnings report, September 6, 2017





PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers a growing range of proprietary products and solutions in leading-edge segments. PCAS generated net sales of €192.0 million in 2016 and employs close to 1000 people in six countries.

To find out more about PCAS, visit: www.pcas.com

















Vincent Touraille / Eric Moissenot


Emmanuel Huynh / Louis-Victor Delouvrier


Financial communication and Investor Relations

Tel. : +33 1 69 79 61 32



Tel. : +33 1 44 71 98 53




This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: PCAS, ZI de la Vigne aux Loups 23, rue Bossuet, LONGJUMEAU FR-91160, France
If you would like to unsubscribe and stop receiving these e-mails click here.